Re ly primary endpoint stroke or systemic embolism
This presentation is the property of its rightful owner.
Sponsored Links
1 / 1

RE-LY: Primary endpoint: Stroke or systemic embolism PowerPoint PPT Presentation


  • 46 Views
  • Uploaded on
  • Presentation posted in: General

0.05. 0.04. Cumulative hazard rate. 0.03. 0.02. 0.01. 0.00. Warfarin. 0. 6. 12. 18. 24. 30. Dabigatran 110 mg. Months. Dabigatran 150 mg. RE-LY: Primary endpoint: Stroke or systemic embolism. Connolly et al . N Eng J Med 2009; 361 :1139–1151.

Download Presentation

RE-LY: Primary endpoint: Stroke or systemic embolism

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Re ly primary endpoint stroke or systemic embolism

0.05

0.04

Cumulative hazard rate

0.03

0.02

0.01

0.00

Warfarin

0

6

12

18

24

30

Dabigatran 110 mg

Months

Dabigatran 150 mg

RE-LY: Primary endpoint: Stroke or systemic embolism

Connolly et al. N Eng J Med 2009;361:1139–1151.


  • Login